How Big Pharma’s China Trials Are Escaping Scrutiny
U.S. supply chains with connections to Xinjiang and the Chinese military are heavily regulated — just not for pharmaceuticals.
Articles
Pharma Bets Big on Chinese Drugmakers
Despite regulatory obstacles, big pharma is so confident in China’s R&D they’re purchasing the rights to medicines that don’t yet exist.
Eleven Days, Part II
To mark the 25th anniversary of the Hainan spy plane crisis, The Wire China is publishing the second installment of its discussions with people who participated in the dramatic showdown. For Part I see our March 29 cover article.
Company in the News: XPeng
The EV giant is hoping AI-driven systems for cars and robots will help drive profits.
Eleven Days, Part I
On the eve of the 25th anniversary of the Hainan spy plane crisis, The Wire China talks with participants and reviews first-person accounts of the incident.
Liberated or Losing? How the U.S. is Faring in Its Trade Struggle with China
The Wire takes stock of the U.S.-China trade picture and the effort to shift global manufacturing back to America a year on from Liberation Day.
How China Gets Caught Between Iran and the U.S.
China remains a big importer of Iranian oil, but its other commercial interests in the country have shifted and narrowed in recent years.
Why China’s Nuclear Ambitions are Worrying the World
Beijing has rapidly expanded its stockpile of nuclear weapons in recent years, while resisting making commitments to transparency.
Chinese AI Makes Its Sales Pitch
China’s AI models dominated headlines during the new year holiday, but struggle to overcome low user adoption at home.
Company in the News: CATL
The world's biggest battery manufacturer is pushing the limits of battery tech and supplies carmakers around the world — but a path further into the U.S. is far from certain.
Slowing the Slump
China’s five-year long property market woes have transformed the sector, but there are signs the government is determined to arrest the slide this year.
Company in the News: Quectel
The unstoppable rise of the leading Internet of Things provider meets pushback against its China ties.